Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-30

Clinical Trial Update: Oral Nifedipine Versus IV Labetalol in Severe Pre Eclampsia [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports a comparative Phase 2/Phase 3 study of oral nifedipine versus intravenous labetalol for severe preeclampsia; current status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine (nifedipine)
  • labetalol (labetalol hydrochloride)

Snippet

Sponsor: Services Institute of Medical Sciences, Pakistan | Conditions: Severe Pre-Eclampsia, Antepartum | Phase 2, Phase 3 | Status: UNKNOWN